Report Cover

Global and China DTaP and Tdap Vaccines Market Insights, Forecast to 2026


DTaP and Tdap Vaccines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global DTaP and Tdap Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the DTaP and Tdap Vaccines market is segmented into
    DTaP
    Td
    Tdap

Segment by Application, the DTaP and Tdap Vaccines market is segmented into
    Adult
    Pediatric

Regional and Country-level Analysis
The DTaP and Tdap Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the DTaP and Tdap Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and DTaP and Tdap Vaccines Market Share Analysis
DTaP and Tdap Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in DTaP and Tdap Vaccines business, the date to enter into the DTaP and Tdap Vaccines market, DTaP and Tdap Vaccines product introduction, recent developments, etc.
The major vendors covered:
    Sanofi Pasteur
    GlaxoSmithKline
    Protein Sciences Corporation
    Novartis AG
    Seqirus
    Merck Sharp & Dohme Corp
    Astellas Pharma US, Inc
    Pfizer Inc
    Johnson & Johnson
    Lanzhou Institute of Biological Products Co., Ltd
    AstraZeneca
    Emergent BioSolutions Inc
1 Study Coverage
    1.1 DTaP and Tdap Vaccines Product Introduction
    1.2 Market Segments
    1.3 Key DTaP and Tdap Vaccines Manufacturers Covered: Ranking by Revenue
    1.4 Market by Type
        1.4.1 Global DTaP and Tdap Vaccines Market Size Growth Rate by Type
        1.4.2 DTaP
        1.4.3 Td
        1.4.4 Tdap
    1.5 Market by Application
        1.5.1 Global DTaP and Tdap Vaccines Market Size Growth Rate by Application
        1.5.2 Adult
        1.5.3 Pediatric
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global DTaP and Tdap Vaccines Market Size, Estimates and Forecasts
        2.1.1 Global DTaP and Tdap Vaccines Revenue 2015-2026
        2.1.2 Global DTaP and Tdap Vaccines Sales 2015-2026
    2.2 Global DTaP and Tdap Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    2.3 DTaP and Tdap Vaccines Historical Market Size by Region (2015-2020)
        2.3.1 Global DTaP and Tdap Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
        2.3.2 Global DTaP and Tdap Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
    2.4 DTaP and Tdap Vaccines Market Estimates and Projections by Region (2021-2026)
        2.4.1 Global DTaP and Tdap Vaccines Sales Forecast by Region (2021-2026)
        2.4.2 Global DTaP and Tdap Vaccines Revenue Forecast by Region (2021-2026)

3 Global DTaP and Tdap Vaccines Competitor Landscape by Players
    3.1 Global Top DTaP and Tdap Vaccines Sales by Manufacturers
        3.1.1 Global DTaP and Tdap Vaccines Sales by Manufacturers (2015-2020)
        3.1.2 Global DTaP and Tdap Vaccines Sales Market Share by Manufacturers (2015-2020)
    3.2 Global DTaP and Tdap Vaccines Manufacturers by Revenue
        3.2.1 Global DTaP and Tdap Vaccines Revenue by Manufacturers (2015-2020)
        3.2.2 Global DTaP and Tdap Vaccines Revenue Share by Manufacturers (2015-2020)
        3.2.3 Global DTaP and Tdap Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
        3.2.4 Global Top 10 and Top 5 Companies by DTaP and Tdap Vaccines Revenue in 2019
        3.2.5 Global DTaP and Tdap Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Global DTaP and Tdap Vaccines Price by Manufacturers
    3.4 Global DTaP and Tdap Vaccines Manufacturing Base Distribution, Product Types
        3.4.1 DTaP and Tdap Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers DTaP and Tdap Vaccines Product Type
        3.4.3 Date of International Manufacturers Enter into DTaP and Tdap Vaccines Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
    4.1 Global DTaP and Tdap Vaccines Market Size by Type (2015-2020)
        4.1.1 Global DTaP and Tdap Vaccines Sales by Type (2015-2020)
        4.1.2 Global DTaP and Tdap Vaccines Revenue by Type (2015-2020)
        4.1.3 DTaP and Tdap Vaccines Average Selling Price (ASP) by Type (2015-2026)
    4.2 Global DTaP and Tdap Vaccines Market Size Forecast by Type (2021-2026)
        4.2.1 Global DTaP and Tdap Vaccines Sales Forecast by Type (2021-2026)
        4.2.2 Global DTaP and Tdap Vaccines Revenue Forecast by Type (2021-2026)
        4.2.3 DTaP and Tdap Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
    4.3 Global DTaP and Tdap Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
    5.1 Global DTaP and Tdap Vaccines Market Size by Application (2015-2020)
        5.1.1 Global DTaP and Tdap Vaccines Sales by Application (2015-2020)
        5.1.2 Global DTaP and Tdap Vaccines Revenue by Application (2015-2020)
        5.1.3 DTaP and Tdap Vaccines Price by Application (2015-2020)
    5.2 DTaP and Tdap Vaccines Market Size Forecast by Application (2021-2026)
        5.2.1 Global DTaP and Tdap Vaccines Sales Forecast by Application (2021-2026)
        5.2.2 Global DTaP and Tdap Vaccines Revenue Forecast by Application (2021-2026)
        5.2.3 Global DTaP and Tdap Vaccines Price Forecast by Application (2021-2026)

6 China by Players, Type and Application
    6.1 China DTaP and Tdap Vaccines Market Size YoY Growth 2015-2026
        6.1.1 China DTaP and Tdap Vaccines Sales YoY Growth 2015-2026
        6.1.2 China DTaP and Tdap Vaccines Revenue YoY Growth 2015-2026
        6.1.3 China DTaP and Tdap Vaccines Market Share in Global Market 2015-2026
    6.2 China DTaP and Tdap Vaccines Market Size by Players (International and Local Players)
        6.2.1 China Top DTaP and Tdap Vaccines Players by Sales (2015-2020)
        6.2.2 China Top DTaP and Tdap Vaccines Players by Revenue (2015-2020)
    6.3 China DTaP and Tdap Vaccines Historic Market Review by Type (2015-2020)
        6.3.1 China DTaP and Tdap Vaccines Sales Market Share by Type (2015-2020)
        6.3.2 China DTaP and Tdap Vaccines Revenue Market Share by Type (2015-2020)
        6.3.3 China DTaP and Tdap Vaccines Price by Type (2015-2020)
    6.4 China DTaP and Tdap Vaccines Market Estimates and Forecasts by Type (2021-2026)
        6.4.1 China DTaP and Tdap Vaccines Sales Forecast by Type (2021-2026)
        6.4.2 China DTaP and Tdap Vaccines Revenue Forecast by Type (2021-2026)
        6.4.3 China DTaP and Tdap Vaccines Price Forecast by Type (2021-2026)
    6.5 China DTaP and Tdap Vaccines Historic Market Review by Application (2015-2020)
        6.5.1 China DTaP and Tdap Vaccines Sales Market Share by Application (2015-2020)
        6.5.2 China DTaP and Tdap Vaccines Revenue Market Share by Application (2015-2020)
        6.5.3 China DTaP and Tdap Vaccines Price by Application (2015-2020)
    6.6 China DTaP and Tdap Vaccines Market Estimates and Forecasts by Application (2021-2026)
        6.6.1 China DTaP and Tdap Vaccines Sales Forecast by Application (2021-2026)
        6.6.2 China DTaP and Tdap Vaccines Revenue Forecast by Application (2021-2026)
        6.6.3 China DTaP and Tdap Vaccines Price Forecast by Application (2021-2026)

7 North America
    7.1 North America DTaP and Tdap Vaccines Market Size YoY Growth 2015-2026
    7.2 North America DTaP and Tdap Vaccines Market Facts & Figures by Country
        7.2.1 North America DTaP and Tdap Vaccines Sales by Country (2015-2020)
        7.2.2 North America DTaP and Tdap Vaccines Revenue by Country (2015-2020)
        7.2.3 U.S.
        7.2.4 Canada

8 Europe
    8.1 Europe DTaP and Tdap Vaccines Market Size YoY Growth 2015-2026
    8.2 Europe DTaP and Tdap Vaccines Market Facts & Figures by Country
        8.2.1 Europe DTaP and Tdap Vaccines Sales by Country
        8.2.2 Europe DTaP and Tdap Vaccines Revenue by Country
        8.2.3 Germany
        8.2.4 France
        8.2.5 U.K.
        8.2.6 Italy
        8.2.7 Russia

9 Asia Pacific
    9.1 Asia Pacific DTaP and Tdap Vaccines Market Size YoY Growth 2015-2026
    9.2 Asia Pacific DTaP and Tdap Vaccines Market Facts & Figures by Country
        9.2.1 Asia Pacific DTaP and Tdap Vaccines Sales by Region (2015-2020)
        9.2.2 Asia Pacific DTaP and Tdap Vaccines Revenue by Region
        9.2.3 China
        9.2.4 Japan
        9.2.5 South Korea
        9.2.6 India
        9.2.7 Australia
        9.2.8 Taiwan
        9.2.9 Indonesia
        9.2.10 Thailand
        9.2.11 Malaysia
        9.2.12 Philippines
        9.2.13 Vietnam

10 Latin America
    10.1 Latin America DTaP and Tdap Vaccines Market Size YoY Growth 2015-2026
    10.2 Latin America DTaP and Tdap Vaccines Market Facts & Figures by Country
        10.2.1 Latin America DTaP and Tdap Vaccines Sales by Country
        10.2.2 Latin America DTaP and Tdap Vaccines Revenue by Country
        10.2.3 Mexico
        10.2.4 Brazil
        10.2.5 Argentina

11 Middle East and Africa
    11.1 Middle East and Africa DTaP and Tdap Vaccines Market Size YoY Growth 2015-2026
    11.2 Middle East and Africa DTaP and Tdap Vaccines Market Facts & Figures by Country
        11.2.1 Middle East and Africa DTaP and Tdap Vaccines Sales by Country
        11.2.2 Middle East and Africa DTaP and Tdap Vaccines Revenue by Country
        11.2.3 Turkey
        11.2.4 Saudi Arabia
        11.2.5 U.A.E

12 Company Profiles
    12.1 Sanofi Pasteur
        12.1.1 Sanofi Pasteur Corporation Information
        12.1.2 Sanofi Pasteur Description and Business Overview
        12.1.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
        12.1.4 Sanofi Pasteur DTaP and Tdap Vaccines Products Offered
        12.1.5 Sanofi Pasteur Recent Development
    12.2 GlaxoSmithKline
        12.2.1 GlaxoSmithKline Corporation Information
        12.2.2 GlaxoSmithKline Description and Business Overview
        12.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
        12.2.4 GlaxoSmithKline DTaP and Tdap Vaccines Products Offered
        12.2.5 GlaxoSmithKline Recent Development
    12.3 Protein Sciences Corporation
        12.3.1 Protein Sciences Corporation Corporation Information
        12.3.2 Protein Sciences Corporation Description and Business Overview
        12.3.3 Protein Sciences Corporation Sales, Revenue and Gross Margin (2015-2020)
        12.3.4 Protein Sciences Corporation DTaP and Tdap Vaccines Products Offered
        12.3.5 Protein Sciences Corporation Recent Development
    12.4 Novartis AG
        12.4.1 Novartis AG Corporation Information
        12.4.2 Novartis AG Description and Business Overview
        12.4.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
        12.4.4 Novartis AG DTaP and Tdap Vaccines Products Offered
        12.4.5 Novartis AG Recent Development
    12.5 Seqirus
        12.5.1 Seqirus Corporation Information
        12.5.2 Seqirus Description and Business Overview
        12.5.3 Seqirus Sales, Revenue and Gross Margin (2015-2020)
        12.5.4 Seqirus DTaP and Tdap Vaccines Products Offered
        12.5.5 Seqirus Recent Development
    12.6 Merck Sharp & Dohme Corp
        12.6.1 Merck Sharp & Dohme Corp Corporation Information
        12.6.2 Merck Sharp & Dohme Corp Description and Business Overview
        12.6.3 Merck Sharp & Dohme Corp Sales, Revenue and Gross Margin (2015-2020)
        12.6.4 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Products Offered
        12.6.5 Merck Sharp & Dohme Corp Recent Development
    12.7 Astellas Pharma US, Inc
        12.7.1 Astellas Pharma US, Inc Corporation Information
        12.7.2 Astellas Pharma US, Inc Description and Business Overview
        12.7.3 Astellas Pharma US, Inc Sales, Revenue and Gross Margin (2015-2020)
        12.7.4 Astellas Pharma US, Inc DTaP and Tdap Vaccines Products Offered
        12.7.5 Astellas Pharma US, Inc Recent Development
    12.8 Pfizer Inc
        12.8.1 Pfizer Inc Corporation Information
        12.8.2 Pfizer Inc Description and Business Overview
        12.8.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
        12.8.4 Pfizer Inc DTaP and Tdap Vaccines Products Offered
        12.8.5 Pfizer Inc Recent Development
    12.9 Johnson & Johnson
        12.9.1 Johnson & Johnson Corporation Information
        12.9.2 Johnson & Johnson Description and Business Overview
        12.9.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
        12.9.4 Johnson & Johnson DTaP and Tdap Vaccines Products Offered
        12.9.5 Johnson & Johnson Recent Development
    12.10 Lanzhou Institute of Biological Products Co., Ltd
        12.10.1 Lanzhou Institute of Biological Products Co., Ltd Corporation Information
        12.10.2 Lanzhou Institute of Biological Products Co., Ltd Description and Business Overview
        12.10.3 Lanzhou Institute of Biological Products Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
        12.10.4 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Products Offered
        12.10.5 Lanzhou Institute of Biological Products Co., Ltd Recent Development
    12.11 Sanofi Pasteur
        12.11.1 Sanofi Pasteur Corporation Information
        12.11.2 Sanofi Pasteur Description and Business Overview
        12.11.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
        12.11.4 Sanofi Pasteur DTaP and Tdap Vaccines Products Offered
        12.11.5 Sanofi Pasteur Recent Development
    12.12 Emergent BioSolutions Inc
        12.12.1 Emergent BioSolutions Inc Corporation Information
        12.12.2 Emergent BioSolutions Inc Description and Business Overview
        12.12.3 Emergent BioSolutions Inc Sales, Revenue and Gross Margin (2015-2020)
        12.12.4 Emergent BioSolutions Inc Products Offered
        12.12.5 Emergent BioSolutions Inc Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Porter's Five Forces Analysis
    13.5 Primary Interviews with Key DTaP and Tdap Vaccines Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 DTaP and Tdap Vaccines Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Tables Table 1. DTaP and Tdap Vaccines Market Segments Table 2. Ranking of Global Top DTaP and Tdap Vaccines Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global DTaP and Tdap Vaccines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million) Table 4. Major Manufacturers of DTaP Table 5. Major Manufacturers of Td Table 6. Major Manufacturers of Tdap Table 7. Global DTaP and Tdap Vaccines Market Size Growth Rate by Application 2020-2026 (K Units) Table 8. Global DTaP and Tdap Vaccines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026 Table 9. Global DTaP and Tdap Vaccines Sales by Regions 2015-2020 (K Units) Table 10. Global DTaP and Tdap Vaccines Sales Market Share by Regions (2015-2020) Table 11. Global DTaP and Tdap Vaccines Revenue by Regions 2015-2020 (US$ Million) Table 12. Global DTaP and Tdap Vaccines Sales Forecast by Region (2021-2026) (K Units) Table 13. Global DTaP and Tdap Vaccines Sales by Manufacturers (2015-2020) (K Units) Table 14. Global DTaP and Tdap Vaccines Sales Share by Manufacturers (2015-2020) Table 15. Global DTaP and Tdap Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 16. Global DTaP and Tdap Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in DTaP and Tdap Vaccines as of 2019) Table 17. DTaP and Tdap Vaccines Revenue by Manufacturers (2015-2020) (US$ Million) Table 18. DTaP and Tdap Vaccines Revenue Share by Manufacturers (2015-2020) Table 19. Key Manufacturers DTaP and Tdap Vaccines Price (2015-2020) (USD/Unit) Table 20. DTaP and Tdap Vaccines Manufacturers Manufacturing Base Distribution and Headquarters Table 21. Manufacturers DTaP and Tdap Vaccines Product Type Table 22. Date of International Manufacturers Enter into DTaP and Tdap Vaccines Market Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans Table 24. Global DTaP and Tdap Vaccines Sales by Type (2015-2020) (K Units) Table 25. Global DTaP and Tdap Vaccines Sales Share by Type (2015-2020) Table 26. Global DTaP and Tdap Vaccines Revenue by Type (2015-2020) (US$ Million) Table 27. Global DTaP and Tdap Vaccines Revenue Share by Type (2015-2020) Table 28. DTaP and Tdap Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit) Table 29. Global DTaP and Tdap Vaccines Sales Share by Type (2021-2026) Table 30. Global DTaP and Tdap Vaccines Sales by Application (2015-2020) (K Units) Table 31. Global DTaP and Tdap Vaccines Sales Share by Application (2015-2020) Table 32. Global DTaP and Tdap Vaccines Sales Share by Application (2021-2026) Table 33. Global DTaP and Tdap Vaccines Sales Market Share Forecast by Application (2021-2026) Table 34. Global DTaP and Tdap Vaccines Revenue by Application (2015-2020) (US$ Million) Table 35. Global DTaP and Tdap Vaccines Revenue Market Share Forecast by Application (2021-2026) Table 36. China DTaP and Tdap Vaccines Sales (K Units) of Key Companies (2015-2020) Table 37. China DTaP and Tdap Vaccines Sales Share by Company (2015-2020) Table 38. China DTaP and Tdap Vaccines Revenue (US$ Million) by Company (2015-2020) Table 39. China DTaP and Tdap Vaccines Sales (K Units) by Type (2015-2020) Table 40. China DTaP and Tdap Vaccines Sales Share by Type (2015-2020) Table 41. China DTaP and Tdap Vaccines Revenue (US$ Million) Market Share by Type (2015-2020) Table 42. China DTaP and Tdap Vaccines Price (K Units) by Type (2015-2020) Table 43. China DTaP and Tdap Vaccines Sales (K Units) by Type (2021-2026) Table 44. China DTaP and Tdap Vaccines Sales Share by Type (2021-2026) Table 45. China DTaP and Tdap Vaccines Revenue (US$ Million) Market Share by Type (2021-2026) Table 46. China DTaP and Tdap Vaccines Revenue Share by Type (2021-2026) Table 47. China DTaP and Tdap Vaccines Price (K Units) by Type (2021-2026) Table 48. China DTaP and Tdap Vaccines Sales (K Units) by Application (2015-2020) Table 49. China DTaP and Tdap Vaccines Sales Share by Application (2015-2020) Table 50. China DTaP and Tdap Vaccines Revenue (US$ Million) Market Share by Application (2015-2020) Table 51. China DTaP and Tdap Vaccines Sales (K Units) by Application (2021-2026) Table 52. China DTaP and Tdap Vaccines Sales Share by Application (2021-2026) Table 53. China DTaP and Tdap Vaccines Revenue (US$ Million) Market Share by Application (2021-2026) Table 54. China DTaP and Tdap Vaccines Revenue Share by Application (2021-2026) Table 55. North America DTaP and Tdap Vaccines Sales by Country (2015-2020) (K Units) Table 56. North America DTaP and Tdap Vaccines Sales Market Share by Country (2015-2020) Table 57. North America DTaP and Tdap Vaccines Revenue by Country (2015-2020) (US$ Million) Table 58. North America DTaP and Tdap Vaccines Revenue Market Share by Country (2015-2020) Table 59. Europe DTaP and Tdap Vaccines Sales by Country (2015-2020) (K Units) Table 60. Europe DTaP and Tdap Vaccines Sales Market Share by Country (2015-2020) Table 61. Europe DTaP and Tdap Vaccines Revenue by Country (2015-2020) (US$ Million) Table 62. Europe DTaP and Tdap Vaccines Revenue Market Share by Country (2015-2020) Table 63. Asia Pacific DTaP and Tdap Vaccines Sales by Region (2015-2020) (K Units) Table 64. Asia Pacific DTaP and Tdap Vaccines Sales Market Share by Region (2015-2020) Table 65. Asia Pacific DTaP and Tdap Vaccines Revenue by Region (2015-2020) (US$ Million) Table 66. Asia Pacific DTaP and Tdap Vaccines Revenue Market Share by Region (2015-2020) Table 67. Latin America DTaP and Tdap Vaccines Sales by Country (2015-2020) (K Units) Table 68. Latin America DTaP and Tdap Vaccines Sales Market Share by Country (2015-2020) Table 69. Latin Americaa DTaP and Tdap Vaccines Revenue by Country (2015-2020) (US$ Million) Table 70. Latin America DTaP and Tdap Vaccines Revenue Market Share by Country (2015-2020) Table 71. Middle East and Africa DTaP and Tdap Vaccines Sales by Country (2015-2020) (K Units) Table 72. Middle East and Africa DTaP and Tdap Vaccines Sales Market Share by Country (2015-2020) Table 73. Middle East and Africa DTaP and Tdap Vaccines Revenue by Country (2015-2020) (US$ Million) Table 74. Middle East and Africa DTaP and Tdap Vaccines Revenue Market Share by Country (2015-2020) Table 75. Sanofi Pasteur Corporation Information Table 76. Sanofi Pasteur Description and Business Overview Table 77. Sanofi Pasteur DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 78. Sanofi Pasteur DTaP and Tdap Vaccines Product Table 79. Sanofi Pasteur Recent Development Table 80. GlaxoSmithKline Corporation Information Table 81. GlaxoSmithKline Description and Business Overview Table 82. GlaxoSmithKline DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 83. GlaxoSmithKline Product Table 84. GlaxoSmithKline Recent Development Table 85. Protein Sciences Corporation Corporation Information Table 86. Protein Sciences Corporation Description and Business Overview Table 87. Protein Sciences Corporation DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 88. Protein Sciences Corporation Product Table 89. Protein Sciences Corporation Recent Development Table 90. Novartis AG Corporation Information Table 91. Novartis AG Description and Business Overview Table 92. Novartis AG DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 93. Novartis AG Product Table 94. Novartis AG Recent Development Table 95. Seqirus Corporation Information Table 96. Seqirus Description and Business Overview Table 97. Seqirus DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 98. Seqirus Product Table 99. Seqirus Recent Development Table 100. Merck Sharp & Dohme Corp Corporation Information Table 101. Merck Sharp & Dohme Corp Description and Business Overview Table 102. Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 103. Merck Sharp & Dohme Corp Product Table 104. Merck Sharp & Dohme Corp Recent Development Table 105. Astellas Pharma US, Inc Corporation Information Table 106. Astellas Pharma US, Inc Description and Business Overview Table 107. Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 108. Astellas Pharma US, Inc Product Table 109. Astellas Pharma US, Inc Recent Development Table 110. Pfizer Inc Corporation Information Table 111. Pfizer Inc Description and Business Overview Table 112. Pfizer Inc DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 113. Pfizer Inc Product Table 114. Pfizer Inc Recent Development Table 115. Johnson & Johnson Corporation Information Table 116. Johnson & Johnson Description and Business Overview Table 117. Johnson & Johnson DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 118. Johnson & Johnson Product Table 119. Johnson & Johnson Recent Development Table 120. Lanzhou Institute of Biological Products Co., Ltd Corporation Information Table 121. Lanzhou Institute of Biological Products Co., Ltd Description and Business Overview Table 122. Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 123. Lanzhou Institute of Biological Products Co., Ltd Product Table 124. Lanzhou Institute of Biological Products Co., Ltd Recent Development Table 125. AstraZeneca Corporation Information Table 126. AstraZeneca Description and Business Overview Table 127. AstraZeneca DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 128. AstraZeneca Product Table 129. AstraZeneca Recent Development Table 130. Emergent BioSolutions Inc Corporation Information Table 131. Emergent BioSolutions Inc Description and Business Overview Table 132. Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 133. Emergent BioSolutions Inc Product Table 134. Emergent BioSolutions Inc Recent Development Table 135. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 136. Key Challenges Table 137. Market Risks Table 138. Main Points Interviewed from Key DTaP and Tdap Vaccines Players Table 139. DTaP and Tdap Vaccines Customers List Table 140. DTaP and Tdap Vaccines Distributors List Table 141. Research Programs/Design for This Report Table 142. Key Data Information from Secondary Sources Table 143. Key Data Information from Primary Sources List of Figures Figure 1. DTaP and Tdap Vaccines Product Picture Figure 2. Global DTaP and Tdap Vaccines Sales Market Share by Type in 2020 & 2026 Figure 3. DTaP Product Picture Figure 4. Td Product Picture Figure 5. Tdap Product Picture Figure 6. Global DTaP and Tdap Vaccines Sales Market Share by Application in 2020 & 2026 Figure 7. Adult Figure 8. Pediatric Figure 9. DTaP and Tdap Vaccines Report Years Considered Figure 10. Global DTaP and Tdap Vaccines Market Size 2015-2026 (US$ Million) Figure 11. Global DTaP and Tdap Vaccines Sales 2015-2026 (K Units) Figure 12. Global DTaP and Tdap Vaccines Market Size Market Share by Region: 2020 Versus 2026 Figure 13. Global DTaP and Tdap Vaccines Sales Market Share by Region (2015-2020) Figure 14. Global DTaP and Tdap Vaccines Sales Market Share by Region in 2019 Figure 15. Global DTaP and Tdap Vaccines Revenue Market Share by Region (2015-2020) Figure 16. Global DTaP and Tdap Vaccines Revenue Market Share by Region in 2019 Figure 17. Global DTaP and Tdap Vaccines Sales Share by Manufacturer in 2019 Figure 18. The Top 10 and 5 Players Market Share by DTaP and Tdap Vaccines Revenue in 2019 Figure 19. DTaP and Tdap Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 20. Global DTaP and Tdap Vaccines Sales Market Share by Type (2015-2020) Figure 21. Global DTaP and Tdap Vaccines Sales Market Share by Type in 2019 Figure 22. Global DTaP and Tdap Vaccines Revenue Market Share by Type (2015-2020) Figure 23. Global DTaP and Tdap Vaccines Revenue Market Share by Type in 2019 Figure 24. Global DTaP and Tdap Vaccines Market Share by Price Range (2015-2020) Figure 25. Global DTaP and Tdap Vaccines Sales Market Share by Application (2015-2020) Figure 26. Global DTaP and Tdap Vaccines Sales Market Share by Application in 2019 Figure 27. Global DTaP and Tdap Vaccines Revenue Market Share by Application (2015-2020) Figure 28. Global DTaP and Tdap Vaccines Revenue Market Share by Application in 2019 Figure 29. China DTaP and Tdap Vaccines Sales Growth Rate 2015-2026 (K Units) Figure 30. China DTaP and Tdap Vaccines Revenue Growth Rate 2015-2026 (US$ Million) Figure 31. China DTaP and Tdap Vaccines Market Share in Global Market 2015-2026 Figure 32. China 5 and 10 Largest DTaP and Tdap Vaccines Players Market Share by Revenue in DTaP and Tdap Vaccines in 2019 Figure 33. China DTaP and Tdap Vaccines Revenue Share by Type (2015-2020) Figure 34. China DTaP and Tdap Vaccines Revenue Growth Rate by Type in 2015 & 2019 Figure 35. China DTaP and Tdap Vaccines Revenue Share by Application (2015-2020) Figure 36. China DTaP and Tdap Vaccines Revenue Growth Rate by Application in 2015 & 2019 Figure 37. North America DTaP and Tdap Vaccines Sales Growth Rate 2015-2020 (K Units) Figure 38. North America DTaP and Tdap Vaccines Revenue Growth Rate 2015-2020 (US$ Million) Figure 39. North America DTaP and Tdap Vaccines Sales Market Share by Country in 2019 Figure 40. North America DTaP and Tdap Vaccines Revenue Market Share by Country in 2019 Figure 41. U.S. DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 42. U.S. DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Canada DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 44. Canada DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. Europe DTaP and Tdap Vaccines Sales Growth Rate 2015-2020 (K Units) Figure 46. Europe DTaP and Tdap Vaccines Revenue Growth Rate 2015-2020 (US$ Million) Figure 47. Europe DTaP and Tdap Vaccines Sales Market Share by Country in 2019 Figure 48. Europe DTaP and Tdap Vaccines Revenue Market Share by Country in 2019 Figure 49. Germany DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 50. Germany DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. France DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 52. France DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. U.K. DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 54. U.K. DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Italy DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 56. Italy DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Russia DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 58. Russia DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Asia Pacific DTaP and Tdap Vaccines Sales Growth Rate 2015-2020 (K Units) Figure 60. Asia Pacific DTaP and Tdap Vaccines Revenue Growth Rate 2015-2020 (US$ Million) Figure 61. Asia Pacific DTaP and Tdap Vaccines Sales Market Share by Region in 2019 Figure 62. Asia Pacific DTaP and Tdap Vaccines Revenue Market Share by Region in 2019 Figure 63. China DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 64. China DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Japan DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 66. Japan DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. South Korea DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 68. South Korea DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. India DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 70. India DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Australia DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 72. Australia DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Taiwan DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 74. Taiwan DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Indonesia DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 76. Indonesia DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Thailand DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 78. Thailand DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Malaysia DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 80. Malaysia DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Philippines DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 82. Philippines DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 83. Vietnam DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 84. Vietnam DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 85. Latin America DTaP and Tdap Vaccines Sales Growth Rate 2015-2020 (K Units) Figure 86. Latin America DTaP and Tdap Vaccines Revenue Growth Rate 2015-2020 (US$ Million) Figure 87. Latin America DTaP and Tdap Vaccines Sales Market Share by Country in 2019 Figure 88. Latin America DTaP and Tdap Vaccines Revenue Market Share by Country in 2019 Figure 89. Mexico DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 90. Mexico DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 91. Brazil DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 92. Brazil DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 93. Argentina DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 94. Argentina DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 95. Middle East and Africa DTaP and Tdap Vaccines Sales Growth Rate 2015-2020 (K Units) Figure 96. Middle East and Africa DTaP and Tdap Vaccines Revenue Growth Rate 2015-2020 (US$ Million) Figure 97. Middle East and Africa DTaP and Tdap Vaccines Sales Market Share by Country in 2019 Figure 98. Middle East and Africa DTaP and Tdap Vaccines Revenue Market Share by Country in 2019 Figure 99. Turkey DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 100. Turkey DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 101. Saudi Arabia DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 102. Saudi Arabia DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 103. U.A.E DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 104. U.A.E DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 105. Porter's Five Forces Analysis Figure 106. DTaP and Tdap Vaccines Value Chain Figure 107. Channels of Distribution Figure 108. Distributors Profiles Figure 109. Bottom-up and Top-down Approaches for This Report Figure 110. Data Triangulation Figure 111. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us